Mowat-Wilson syndrome
Log in to starLast updated Nov 3, 2026
A child with Hirschsprung disease, severe intellectual disability, and absent speech has distinctive facies with widely spaced eyes, broad nasal bridge, and uplifted earlobes.
AD, almost always de novo; ZEB2 (zinc finger E-box-binding homeobox 2, a transcriptional repressor); truncating variants or deletions causing loss of function.
The ZEB2 protein is a zinc finger transcription factor that binds SMAD proteins and represses its target genes in response to TGF-beta signaling. It is needed for neural crest development, which fits the features of the syndrome: mice lacking both copies fail to develop because the neural crest is abnormal. In mice, the protein is also required for the differentiation and guidance of cortical neurons (relevant to seizures) and interacts with SOX10, a protein critical for the enteric nervous system (relevant to Hirschsprung disease).
The disease mechanism is loss of function. Most variants are large deletions or frameshift or nonsense variants. Even an early stop codon escapes nonsense-mediated decay in blood, so a truncated protein is made, and the lack of functional domains in that protein is thought to cause the features. A dominant-negative effect has been proposed, but deletions of ZEB2 and its neighbors give the same classic picture, which argues against it.
- Whole-gene deletion: earlier and more drug-resistant epilepsy than variants that leave a protein.
- Missense, splice site, or in-frame variants: under 5% of cases; a milder face, some speech, or nonsyndromic intellectual disability.
- Distinctive facies: hypertelorism, broad nasal bridge, uplifted earlobes, pointed chin
- Hirschsprung disease (44% biopsy-proven)
- Intellectual disability (severe), absent/limited speech
- Seizures, microcephaly
- Congenital heart defects, genitourinary anomalies
- Clinical recognition of the distinctive facies with severe intellectual disability, often with Hirschsprung disease
- Molecular confirmation by ZEB2 sequencing and deletion/duplication analysis (most variants are de novo)
- Suction rectal biopsy to confirm Hirschsprung disease; echocardiogram, renal ultrasound, and brain MRI (corpus callosum)
- Surgical management of Hirschsprung disease; ongoing bowel and constipation management
- Antiseizure medication for epilepsy; developmental, speech, and physical therapy
- Cardiology, nephrology/urology, and ophthalmology surveillance for associated anomalies
- Genetic counseling: typically de novo with low recurrence risk (germline mosaicism reported)
"Mow the Mohawk": Microcephaly, Open-mouth expression, Widely-spaced eyes, absent corpus callosum, Transcription factor mutation (ZEB2), weight down (growth restriction), Hirschsprung's & hypospadias, epilepsy, heart defects, kidney defects
"Zero Exit from Bowels in ZEB2": Hirschsprung disease (absent ganglion cells in colon) occurs in ~50% of patients.
